Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 32888767 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | severe acute respiratory syndrome | Middle Eastern | NA | NA | unclassified | |
| here, five severe acute respiratory syndrome coronavirus 2 (sars-cov-2) non-structural proteins (nsps) (nsp7, nsp8, nsp9, nsp12, and nsp13) were screened to identify potential human leukocyte antigen (hla) binding peptides. | |||||||
| 32888767 | HLA (HLA) | severe acute respiratory syndrome | Middle Eastern | NA | NA | unclassified | |
| notably, hla biding peptides are conserved among sars-cov-2, severe acute respiratory syndrome coronavirus (sars-cov), and middle eastern respiratory syndrome coronavirus (mers-cov). | |||||||
| 32986250 | HLA-CLASS I (HLA CLASS II) | severe acute respiratory syndrome | Mexican | NA | NA | unclassified | |
| a bioinformatic prediction of t cell epitopes and their restricted hla class i and ii alleles was performed to obtain immunogenic epitopes and hla alleles from the spike protein of the severe acute respiratory syndrome coronavirus 2 virus. | |||||||
| 33220791 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | severe acute respiratory syndrome | NA | NA | NA | unclassified | |
| mass spectrometry is used to identify 526 unique sequences from the severe acute respiratory syndrome coronavirus 2 (sars-cov-2) spike glycoprotein extracellular domain in a complex with human leukocyte antigen class ii molecules on antigen-presenting cells from a panel of healthy donors selected to represent a majority of allele usage from this highly polymorphic molecule. | |||||||
| 34166618 | HLA-CLASS I (HLA CLASS II) | severe acute respiratory syndrome | NA | NA | NA | unclassified | |
| using hla peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (sars-cov-2)-derived peptides presented by highly prevalent hla class i (hla-i) molecules by using infected cells as well as overexpression of sars-cov-2 genes. | |||||||
| 34166618 | HLA-CLASS I (HLA-I) | severe acute respiratory syndrome | NA | NA | NA | unclassified | |
| using hla peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (sars-cov-2)-derived peptides presented by highly prevalent hla class i (hla-i) molecules by using infected cells as well as overexpression of sars-cov-2 genes. | |||||||
| 34086357 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | severe acute respiratory syndrome | Asian | NA | NA | unclassified | |
| identification of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) t-cell epitopes and generation of peptide-human leukocyte antigen (peptide-hla) tetramers facilitate direct ex vivo analyses of sars-cov-2-specific t cells and their t-cell receptor (tcr) repertoires. | |||||||
| 34338446 | HLA (HLA) | severe acute respiratory syndrome | African American | NA | NA | unclassified | |
| specific hla alleles may affect the predisposition to severe covid-19 due to their role in presenting viral peptides to launch the adaptive immune response to severe acute respiratory syndrome coronavirus 2 (sars-cov-2). | |||||||
| 34338446 | HLA (HLA) | severe acute respiratory syndrome | African American | NA | NA | unclassified | |
| specific hla alleles may affect the predisposition to severe covid-19 because of their role in presenting viral peptides to launch the adaptive immune response to severe acute respiratory syndrome coronavirus 2 (sars-cov-2). | |||||||
| 34414379 | HLA-A*02 | severe acute respiratory syndrome | NA | NA | NA | unclassified | |
| we purify and activate cd8+ t cells from blood samples from hla-a2 that are negative for severe acute respiratory syndrome coronavirus 2 (sars-cov-2). | |||||||
Copyright 2024